Raymond James & Associates Grows Stock Position in AptarGroup, Inc. (NYSE:ATR)

Raymond James & Associates increased its holdings in shares of AptarGroup, Inc. (NYSE:ATR – Get Rating) by 9.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 147,067 shares of the industrial products company’s stock after buying an additional 12,750 shares during the quarter. Raymond James & Associates owned about 0.23% of AptarGroup worth $16,174,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Rockefeller Capital Management L.P. raised its holdings in shares of AptarGroup by 76.3% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 328 shares of the industrial products company’s stock worth $31,000 after purchasing an additional 142 shares during the period. Riverview Trust Co raised its holdings in shares of AptarGroup by 53.1% in the 4th quarter. Riverview Trust Co now owns 375 shares of the industrial products company’s stock worth $41,000 after purchasing an additional 130 shares during the period. CWM LLC raised its holdings in shares of AptarGroup by 58.3% in the 3rd quarter. CWM LLC now owns 551 shares of the industrial products company’s stock worth $52,000 after purchasing an additional 203 shares during the period. Romano Brothers AND Company purchased a new position in shares of AptarGroup in the 4th quarter worth about $66,000. Finally, Ellevest Inc. raised its holdings in shares of AptarGroup by 107.5% in the 3rd quarter. Ellevest Inc. now owns 606 shares of the industrial products company’s stock worth $58,000 after purchasing an additional 314 shares during the period. 89.37% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other AptarGroup news, insider Marc Prieur sold 6,000 shares of AptarGroup stock in a transaction on Friday, May 5th. The stock was sold at an average price of $119.00, for a total transaction of $714,000.00. Following the sale, the insider now owns 25,028 shares of the company’s stock, valued at approximately $2,978,332. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, Director Maritza Gomez Montiel sold 1,500 shares of the business’s stock in a transaction on Tuesday, February 21st. The stock was sold at an average price of $114.67, for a total value of $172,005.00. Following the sale, the director now owns 4,024 shares of the company’s stock, valued at approximately $461,432.08. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Marc Prieur sold 6,000 shares of the business’s stock in a transaction on Friday, May 5th. The stock was sold at an average price of $119.00, for a total value of $714,000.00. Following the completion of the sale, the insider now directly owns 25,028 shares in the company, valued at approximately $2,978,332. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 72,060 shares of company stock valued at $8,248,427. Insiders own 1.00% of the company’s stock.

AptarGroup Price Performance

Shares of ATR opened at $120.58 on Tuesday. The firm has a market cap of $7.89 billion, a price-to-earnings ratio of 34.75, a PEG ratio of 4.30 and a beta of 0.64. The stock has a 50 day moving average of $117.25 and a 200-day moving average of $112.21. The company has a current ratio of 1.42, a quick ratio of 0.93 and a debt-to-equity ratio of 0.45. AptarGroup, Inc. has a 52 week low of $90.23 and a 52 week high of $122.50.

AptarGroup (NYSE:ATR – Get Rating) last announced its quarterly earnings results on Friday, April 28th. The industrial products company reported $0.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.05. The business had revenue of $860.07 million for the quarter, compared to the consensus estimate of $829.92 million. AptarGroup had a return on equity of 12.53% and a net margin of 6.94%. The business’s revenue was up 1.8% on a year-over-year basis. During the same quarter last year, the business posted $0.96 EPS. As a group, analysts forecast that AptarGroup, Inc. will post 4.04 EPS for the current year.

AptarGroup Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 25th. Investors of record on Thursday, May 4th will be issued a $0.38 dividend. This represents a $1.52 annualized dividend and a dividend yield of 1.26%. The ex-dividend date of this dividend is Wednesday, May 3rd. AptarGroup’s dividend payout ratio (DPR) is 43.80%.

Wall Street Analyst Weigh In

Several brokerages recently commented on ATR. Wells Fargo & Company raised their target price on AptarGroup from $121.00 to $132.00 and gave the company an “overweight” rating in a report on Tuesday, February 21st. Bank of America raised their target price on AptarGroup from $132.00 to $152.00 and gave the company a “buy” rating in a report on Thursday, April 20th. Deutsche Bank Aktiengesellschaft raised their target price on AptarGroup from $130.00 to $134.00 in a report on Monday, May 1st. StockNews.com began coverage on AptarGroup in a report on Thursday, March 16th. They set a “buy” rating on the stock. Finally, TheStreet upgraded AptarGroup from a “c+” rating to a “b-” rating in a report on Tuesday, January 17th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, AptarGroup has a consensus rating of “Moderate Buy” and an average target price of $131.33.

AptarGroup Profile

(Get Rating)

AptarGroup, Inc engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. It operates through the following segments: Pharma, Beauty and Home, and Food and Beverage.